LUNG CANCER (NON-SMALL CELL)
Clinical trials for LUNG CANCER (NON-SMALL CELL) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (NON-SMALL CELL) trials appear
Sign up with your email to follow new studies for LUNG CANCER (NON-SMALL CELL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced lung cancer: SKB571 trial launches
Disease control Recruiting nowThis study tests a new drug called SKB571 in 295 adults with advanced non-small cell lung cancer. The goal is to see if it shrinks tumors and how safe it is. Participants receive the drug alone until their cancer worsens or side effects become too severe.
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 16, 2026 22:33 UTC
-
Inhaled virus therapy takes on advanced lung tumors
Disease control Recruiting nowThis study tests an inhaled treatment called KB707 for people with advanced solid tumors that have spread to the lungs. KB707 is a modified virus designed to trigger the immune system to attack cancer cells. The trial involves 250 adults who have not responded to standard treatme…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE1, PHASE2 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated May 16, 2026 22:33 UTC
-
New hope for tough cancers: targeted drug MBRC-201 enters human trials
Disease control Recruiting nowThis study tests a new drug called MBRC-201 in people with advanced solid tumors (like prostate, breast, lung, colorectal, or pancreatic cancer) that have not responded to standard treatments. The goal is to find the best dose and see if it can shrink tumors or slow their growth.…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated May 16, 2026 22:30 UTC
-
New hope for KRAS lung cancer: drug duo targets tough mutation
Disease control Recruiting nowThis study tests a combination of two drugs, IBI351 and cetuximab β, in people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. The goal is to see if this treatment can shrink tumors or slow the cancer's growth. About 48 adults who hav…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New study aims to boost quality of life for veterans battling lung cancer
Symptom relief Recruiting nowThis study looks at whether giving veterans with lung cancer extra support can help them feel better day-to-day. Researchers will track quality of life, emergency room visits, and hospital stays over one year. The goal is to find simple ways to improve care for those who served.
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: NA • Sponsor: Palo Alto Veterans Institute for Research • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC
-
Sweating before surgery: could exercise boost lung cancer fight?
Knowledge-focused Recruiting nowThis study looks at whether doing intense exercise for two weeks before lung cancer surgery can change the tumor's surroundings and help the immune system fight better. Researchers will compare people who exercise with those who don't, and check tumor samples for changes. The goa…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: NA • Sponsor: University of Arizona • Aim: Knowledge-focused
Last updated May 16, 2026 22:31 UTC
-
Robots vs cameras: which surgery helps lung cancer patients live longer?
Knowledge-focused Recruiting nowThis study looks at 450 people with central lung cancer who need a type of surgery called sleeve lobectomy. Researchers want to see if using a robotic system (RATS) leads to better long-term survival and recovery compared to the standard video-assisted method (VATS). The goal is …
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated May 16, 2026 22:29 UTC
-
New tests aim to take the guesswork out of lung cancer immunotherapy
Knowledge-focused Recruiting nowThis study looks at new ways to predict if immunotherapy drugs (dostarlimab and pembrolizumab) will work for people with advanced lung cancer that has come back. Researchers will use blood tests, lab-grown tumor models, and special PET scans to see if these tools can forecast tre…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated May 16, 2026 22:28 UTC
-
Immunotherapy before lung surgery: which approach works best?
Knowledge-focused Recruiting nowThis study watches 500 lung cancer patients who received immunotherapy before any other treatment. Researchers want to see if removing the whole lung or just part of it leads to better outcomes, and whether surgery is better than other treatments like radiation. The goal is to le…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC
-
Study: muscle loss and poor nutrition may signal higher surgery risks in lung cancer patients
Knowledge-focused Recruiting nowThis study is observing 142 adults having lung cancer surgery to see if their nutrition and muscle health can predict complications, hospital stay length, and survival. Researchers will use blood tests, CT scans, and ultrasound to measure these factors before surgery. The goal is…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC